OWC Pharmaceutical Research (OWC Pharmaceutical Research) COGS-to-Revenue : 0.00 (As of Sep. 2019)

View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research COGS-to-Revenue?

OWC Pharmaceutical Research's Cost of Goods Sold for the three months ended in Sep. 2019 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2019 was $0.00 Mil.

OWC Pharmaceutical Research's COGS to Revenue for the three months ended in Sep. 2019 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. OWC Pharmaceutical Research's Gross Margin % for the three months ended in Sep. 2019 was N/A%.

OWC Pharmaceutical Research COGS-to-Revenue Historical Data

The historical data trend for OWC Pharmaceutical Research's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research COGS-to-Revenue Chart

OWC Pharmaceutical Research Annual Data

Trend

Dec08

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

COGS-to-Revenue

Get a 7-Day Free Trial

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

OWC Pharmaceutical Research COGS-to-Revenue Calculation

OWC Pharmaceutical Research's COGS to Revenue for the fiscal year that ended in Dec. 2018 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

OWC Pharmaceutical Research's COGS to Revenue for the quarter that ended in Sep. 2019 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

OWC Pharmaceutical Research (OTCPK:OWCP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

OWC Pharmaceutical Research's Gross Margin % for the three months ended in Sep. 2019 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

OWC Pharmaceutical Research COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ben Gurion Street, Ramat Gan, ISR, 5257334

Website

http://www.owcpharma.com

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.

Executives

Asher Zwebner

director, officer: CHIEF FINANCIAL OFFICER

CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387